HomeCompareDELRF vs KMB

DELRF vs KMB: Dividend Comparison 2026

DELRF yields 119.76% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DELRF wins by $2.3K in total portfolio value
10 years
DELRF
DELRF
● Live price
119.76%
Share price
$1.67
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48.2K
Annual income
$28.65
Full DELRF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — DELRF vs KMB

📍 DELRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDELRFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DELRF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DELRF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DELRF
Annual income on $10K today (after 15% tax)
$10,179.64/yr
After 10yr DRIP, annual income (after tax)
$24.35/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, KMB beats the other by $4,414.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DELRF + KMB for your $10,000?

DELRF: 50%KMB: 50%
100% KMB50/50100% DELRF
Portfolio after 10yr
$47.1K
Annual income
$2,625.50/yr
Blended yield
5.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

DELRF
No analyst data
Altman Z
2.1
Piotroski
6/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DELRF buys
0
KMB buys
0
No recent congressional trades found for DELRF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDELRFKMB
Forward yield119.76%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%17%
Portfolio after 10y$48.2K$45.9K
Annual income after 10y$28.65$5,222.34
Total dividends collected$17.0K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DELRF vs KMB ($10,000, DRIP)

YearDELRF PortfolioDELRF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$16,688$5,988.02$11,314$614.45+$5.4KDELRF
2$22,526$4,669.55$12,867$760.19+$9.7KDELRF
3$27,048$2,945.34$14,713$945.27+$12.3KDELRF
4$30,594$1,652.63$16,924$1,181.90+$13.7KDELRF
5$33,609$873.50$19,596$1,486.64+$14.0KDELRF
6$36,410$448.40$22,850$1,882.16+$13.6KDELRF
7$39,186$227.00$26,849$2,399.80+$12.3KDELRF
8$42,043$114.16$31,812$3,083.36+$10.2KDELRF
9$45,043$57.24$38,033$3,994.72+$7.0KDELRF
10$48,225$28.65$45,918$5,222.34+$2.3KDELRF

DELRF vs KMB: Complete Analysis 2026

DELRFStock

De La Rue plc designs, manufactures, and delivers banknotes in the United Kingdom, the Middle East, Africa, Asia, the Americas, Rest of Europe, and internationally. It operates through Currency, Authentication, and Identity Solutions. The company offers printed banknotes, and polymer and security features. It also provides range of physical solutions, such as tax stamps, authentication labels, and cheques and bank cards, as well as ID security components, including polycarbonate. In addition, it offers digital solutions, such as DLR Certify, a government revenue solution; and Tracelogy for brand protection, as well as licensing platform. Further, the company provides trading and non-trading, as well as insurance services. It serves the governments, central banks, and commercial organizations. The company was founded in 1813 and is headquartered in Basingstoke, the United Kingdom.

Full DELRF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this DELRF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DELRF vs SCHDDELRF vs JEPIDELRF vs ODELRF vs KODELRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.